A detailed history of Squarepoint Ops LLC transactions in Arvinas, Inc. stock. As of the latest transaction made, Squarepoint Ops LLC holds 118,899 shares of ARVN stock, worth $3.22 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
118,899
Previous 81,871 45.23%
Holding current value
$3.22 Million
Previous $3.38 Million 6.33%
% of portfolio
0.01%
Previous 0.01%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$24.46 - $40.4 $905,704 - $1.5 Million
37,028 Added 45.23%
118,899 $3.17 Million
Q1 2024

May 15, 2024

BUY
$36.38 - $52.31 $2.74 Million - $3.94 Million
75,269 Added 1140.09%
81,871 $3.38 Million
Q4 2023

Feb 14, 2024

SELL
$14.19 - $42.33 $1.17 Million - $3.5 Million
-82,686 Reduced 92.61%
6,602 $271,000
Q2 2023

Aug 14, 2023

BUY
$21.73 - $31.43 $1.1 Million - $1.6 Million
50,813 Added 132.07%
89,288 $2.22 Million
Q1 2023

May 15, 2023

BUY
$26.15 - $37.26 $1.01 Million - $1.43 Million
38,475 New
38,475 $1.05 Million
Q3 2022

Nov 14, 2022

SELL
$41.87 - $57.99 $1.57 Million - $2.18 Million
-37,598 Reduced 49.74%
37,989 $1.69 Million
Q2 2022

Aug 15, 2022

BUY
$36.01 - $74.24 $1.69 Million - $3.49 Million
47,047 Added 164.85%
75,587 $3.18 Million
Q1 2022

May 16, 2022

BUY
$60.27 - $81.57 $1.39 Million - $1.88 Million
23,001 Added 415.26%
28,540 $1.92 Million
Q4 2021

Feb 14, 2022

SELL
$65.85 - $96.21 $1.57 Million - $2.29 Million
-23,770 Reduced 81.1%
5,539 $455,000
Q3 2021

Nov 15, 2021

BUY
$73.2 - $107.87 $765,159 - $1.13 Million
10,453 Added 55.44%
29,309 $2.41 Million
Q2 2021

Aug 16, 2021

BUY
$60.45 - $84.26 $257,033 - $358,273
4,252 Added 29.12%
18,856 $1.45 Million
Q1 2021

May 17, 2021

SELL
$58.19 - $91.37 $787,892 - $1.24 Million
-13,540 Reduced 48.11%
14,604 $965,000
Q4 2020

Feb 16, 2021

SELL
$20.19 - $84.93 $931,102 - $3.92 Million
-46,117 Reduced 62.1%
28,144 $2.39 Million
Q3 2020

Nov 16, 2020

BUY
$22.99 - $36.34 $1.1 Million - $1.73 Million
47,635 Added 178.9%
74,261 $1.75 Million
Q2 2020

Aug 14, 2020

BUY
$29.88 - $56.74 $795,584 - $1.51 Million
26,626 New
26,626 $893,000
Q1 2020

May 15, 2020

SELL
$33.0 - $54.5 $549,318 - $907,207
-16,646 Closed
0 $0
Q4 2019

Feb 14, 2020

SELL
$15.39 - $44.38 $138,002 - $397,955
-8,967 Reduced 35.01%
16,646 $684,000
Q3 2019

Nov 14, 2019

BUY
$21.55 - $27.61 $551,960 - $707,174
25,613 New
25,613 $552,000

Others Institutions Holding ARVN

About ARVINAS, INC.


  • Ticker ARVN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,205,300
  • Market Cap $1.44B
  • Description
  • Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...
More about ARVN
Track This Portfolio

Track Squarepoint Ops LLC Portfolio

Follow Squarepoint Ops LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.